Solomon T. Japanese encephalitis. In: Magill A, editor. Hunter’s tropical medicine and emerging infectious disease, expert consult—online and print. 9th ed. Elsevier Health Sciences; 2013. p. 358–365.
Schuh AJ, Ward MJ, Leigh Brown AJ, Barrett ADT. Phylogeography of Japanese encephalitis virus: genotype is associated with climate. PLoS Negl Trop Dis. 2013;7(8) https://doi.org/10.1371/journal.pntd.0002411.
Zhang J, Zhao Q, Guo X, Zuo S, Cheng J, Jia N. Isolation and genetic characteristics of human genotype 1 Japanese Encephalitis Virus, China, 2009. PLoS One. 2011;6(1) https://doi.org/10.1371/journal.pone.0016418.
Tajima S, Yagasaki K, Kotaki A, et al. In vitro growth, pathogenicity and serological characteristics of the japanese encephalitis virus genotype v muar strain. J Gen Virol. 2015;96(9):2661–9. https://doi.org/10.1099/vir.0.000213.
Li Y-X. Japanese encephalitis, Tibet, China. Emerg Infect Dis. 2011;17(5):934–6.
Nga PT, del Carmen Parquet M, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol. 2004;85(6):1625–31. https://doi.org/10.1099/vir.0.79797-0.
Gao X, Liu H, Wang H, Fu S, Guo Z, Liang G. Southernmost Asia is the source of Japanese encephalitis virus (genotype 1) diversity from which the viruses disperse and evolve throughout Asia. PLoS Negl Trop Dis. 2013;7(9):1–10. https://doi.org/10.1371/journal.pntd.0002459.
Schuh AJ, Tesh RB, Barrett ADT. Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978. J Gen Virol. 2011;92(3):516–27. https://doi.org/10.1099/vir.0.027110-0.
Schuh AJ, Li L, Tesh RB, Innis BL, Barrett ADT. Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951. J Gen Virol. 2010;91(1):95–102. https://doi.org/10.1099/vir.0.013631-0.
Pan X-L, Liu H, Wang H-Y, Fu SH, Liu HZ, Zhang HL, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol. 2011;85(19):9847–53. https://doi.org/10.1128/JVI.00825-11.
Takhampunya R, Kim HC, Tippayachai B, Kengluecha A, Klein TA, Lee WJ, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J. 2011;8:449. https://doi.org/10.1186/1743-422X-8-449.
Li MH, Fu SH, Chen WX, et al. Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis. 2011;5(7):1–7. https://doi.org/10.1371/journal.pntd.0001231.
• Cao L, Fu S, Gao X, et al. Low protective efficacy of the current Japanese encephalitis vaccine against the emerging genotype 5 Japanese encephalitis virus. PLoS Negl Trop Dis. 2016;10(5):1–12. https://doi.org/10.1371/journal.pntd.0004686. Presents both in vivo and in vitro tests demonstrating poor protective efficacy of current genotype III-based inactivated and live-attenuated vaccines against genotype V
Le Flohic G, Porphyre V, Barbazan P, Gonzalez JP. Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology. PLoS Negl Trop Dis. 2013;7(9):5–11. https://doi.org/10.1371/journal.pntd.0002208.
Cao M, Feng Z, Zhang J, Ma J, Li X. Contextual risk factors for regional distribution of Japanese encephalitis in the People’s Republic of China. Tropical Med Int Health. 2010;15(8):918–23. https://doi.org/10.1111/j.1365-3156.2010.02563.x.
Van Den Hurk AF, Ritchie SA, Johansen CA, Mackenzie JS, Smith GA. Domestic pigs and Japanese encephalitis virus infection, Australia. Emerg Infect Dis. 2008;14(11):1736–8. https://doi.org/10.3201/eid1411.071368.
Lord JS, Gurley ES, Pulliam JRC. Rethinking Japanese encephalitis virus transmission: a framework for implicating host and vector species. PLoS Negl Trop Dis. 2015;9(12):1–7. https://doi.org/10.1371/journal.pntd.0004074.
Kumari R, Kumar K, Rawat A, Singh G, Yadav NK, Chauhan LS. First indigenous transmission of Japanese encephalitis in urban areas of National Capital Territory of Delhi, India. Tropical Med Int Health. 2013;18(6):743–9. https://doi.org/10.1111/tmi.12104.
•• Cappelle J, Duong V, Pring L, Kong L, Yakovleff M, Prasetyo DB, et al. Intensive circulation of Japanese encephalitis virus in peri-urban sentinel pigs near Phnom. PLoS Negl Trop Dis. 2016;10(12):1–14. https://doi.org/10.1371/journal.pntd.0005149. Demonstrates a high prevalence of JE seropositivity in pigs in surveillance of piggeries in densely-populated outskirts of Phnom Penh, Cambodia
Lindahl JF, Stahl K, Chirico J, Boqvist S, Thu HTV, Magnusson U. Circulation of Japanese encephalitis virus in pigs and mosquito vectors within Can Tho City, Vietnam. PLoS Negl Trop Dis. 2013;7(4):1–8. https://doi.org/10.1371/journal.pntd.0002153.
• Ricklin ME, García-Nicolás O, Brechbühl D, Python S, Zumkehr B, Nougairede A, et al. Vector-free transmission and persistence of Japanese encephalitis virus in pigs. Nat Commun. 2016;7:10832. https://doi.org/10.1038/ncomms10832. Demonstrates under experimental conditions transmission of JEV between pigs via oronasal secretions; clinical and histological signs of infection did not differ between routes of transmission
Gajanana A, Thenmozhi V, Samuel PP, Reuben R. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Bull World Health Organ. 1995;73(2):237–44.
Halstead SB, Thomas SJ. Japanese encephalitis: new options for active immunization. Clin Infect Dis. 2010;50(8):1155–64. https://doi.org/10.1086/651271.
Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry. 2000;68(4):405–15. https://doi.org/10.1136/jnnp.68.4.405.
Hills SL, Rabe IB, Fisher M. Chapter 3: infectious diseases related to travel, Japanese encephalitis. Centers for Disease Control Yellow Book. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/japanese-encephalitis. Published 2017.
Wang H, Liang G. Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manag. 2015;11:435–48.
Ravanini P, Huhtamo E, Ilaria V, Crobu M.G., Nicosia A.M., Servino L., Rivasi F., Allegrini S., Miglio U., Magri A., Minisini R., Vapalahti O., Boldorini R. Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy. Euro Surveill. 2012;17(28).
• Simon-Loriere PDE. Autochthonous Japanese encephalitis with yellow fever coinfection in Africa. N Engl J Med. 2017;376(15):13–5. Report of a JE infection in Angola in 2016, representing what would be the first autochthonously-acquired infection outside of Asia or Oceania
Wang L, Zhang W, Ding F, et al. Spatiotemporal patterns of Japanese encephalitis in China, 2002-2010. PLoS Negl Trop Dis. 2013;7(6):1–8. https://doi.org/10.1371/journal.pntd.0002285.
Burke DS, Leake C. Japanese encephalitis. In: Monath T, editor. The arboviruses: epidemiology and ecology, vol. 3. Boca Raton: CRC Press; 1988.
Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine. 2000;18(Supplement 2):1–25.
•• Campbell G, Hills S, Fischer M, Jacobson J, Hoke C, Hombach J, et al. Estimated global incidence of Japanese encephalitis. Bull World Health Organ. 2011;89(10):766–74. https://doi.org/10.2471/BLT.10.085233. Most recent comprehensive assessment of global JE burden, estimating an annual incidence of 68,000 cases based on extrapolation of published sentinel surveillance studying
Heffelfinger JD. Japanese encephalitis surveillance and immunization—Asia and the western Pacific, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(33):653–7. http://www.ncbi.nlm.nih.gov/pubmed/23965827
Metelka J, Robertson C, Stephen C. Japanese encephalitis: estimating future trends in Asia. AIMS Public Health. 2015;2(4):601–15. https://doi.org/10.3934/publichealth.2015.4.601.
Testa G, Borghese L, Steinbeck JA, Bru O. Meeting report. Cell. 2007;153–156. https://doi.org/10.1016/j.stem.2007.07.006.
Report M. Meeting report. Rejuvenation Res. 2005;8(4):264–6. https://doi.org/10.1038/embor.2009.169.
•• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2017 global summary. http://apps.who.int/immunization_monitoring/globalsummary/. Published 2017. Accessed 18 Dec 2017. Provides data on incidence and vaccination rates, as self-reported by individual countries.
Paul RC, Rahman M, Gurley ES, et al. A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh. Am J Trop Med Hyg. 2011;85(2):379–85. https://doi.org/10.4269/ajtmh.2011.10-0706.
Touch S, Hills S, Sokhal B, Samnang C, Sovann L, Khieu V, et al. Epidemiology and burden of disease from Japanese encephalitis in Cambodia: results from two years of sentinel surveillance. Tropical Med Int Health. 2009;14(11):1365–73. https://doi.org/10.1111/j.1365-3156.2009.02380.x.
Tarantola A, Goutard F, Newton P, de Lamballerie X, Lortholary O, Cappelle J, et al. Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the Mekong region. PLoS Negl Trop Dis. 2014;8(1):4. https://doi.org/10.1371/journal.pntd.0002533.
Lindahl J. Japanese encephalitis virus in pigs and vectors in the Mekong Delta with special reference to urban farming. 2012.
Yang Y, Liang N, Tan Y, Xie Z. Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China. Int J Infect Dis. 2016;45:135–8. https://doi.org/10.1016/j.ijid.2016.03.004.
Huanyu W, Yixing L, Xiaofeng L, Guodong L. Japanese encephalitis in mainland China. Jpn J Infect Dis. 2009;62:331–6.
Yin Z, Wang H, Yang J, et al. Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People’s Republic of China. Am J Trop Med Hyg. 2010;83(4):766–73. https://doi.org/10.4269/ajtmh.2010.09-0748.
Directorate of National Vector Borne Disease Control Programme - Delhi. State wise number of AES/JE Cases and Deaths from 2010–2017. Dir Natl Vector Borne Dis Control Program. 2017:11651. http://nvbdcp.gov.in/Doc/je-aes.pdf.
Murhekar MV, Oak C, Ranjan P, Kanagasabai K, Shinde S, Pandey AK, et al. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: implications for Japanese encephalitis control. Indian J Med Res. 2017;145(February):63–9. https://doi.org/10.4103/ijmr.IJMR.
Kumar D, Singh AJ. Response of various stakeholders towards newly introduced Japanese encephalitis vaccine in a North Indian State. J Vaccines. 2014;2014:1–4.
Kari K, Liu W, Gautama K, Mammen MP, Clemens JD, Nisalak A, et al. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med. 2006;4(1):8. https://doi.org/10.1186/1741-7015-4-8.
Ompusunggu S, Hills SL, Maha MS, Moniaga VA, Susilarini NK, Widjaya A, et al. Confirmation of Japanese encephalitis as an endemic human disease through sentinel surveillance in Indonesia. Am J Trop Med Hyg. 2008;79(6):963–70.
World Health Organization. Japanese Encephalitis reported cases. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencejapenc.html. Published 2017. Accessed 1 Jan 2017.
Wagner H. Protecting the environment from the impact of the growing industrialization of livestock production in East Asia. In: 26th Session of Animal Production and Health Commission of Asia and the Pacific, Food and Agriculture Administration of United Nations. 2002. http://www.fao.org/docrep/005/ac801e/ac801e09.htm.
Vallée J, Dubot-Pérès A, Ounaphom P, Sayavong C, Bryant JE, Gonzalez JP. Spatial distribution and risk factors of dengue and Japanese encephalitis virus infection in urban settings: the case of Vientiane, Lao PDR. Tropical Med Int Health. 2009;14(9):1134–42. https://doi.org/10.1111/j.1365-3156.2009.02319.x.
Solomon T, Thi TT, Lewthwaite P, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ. 2008;86(3):178–86. https://doi.org/10.2471/BLT.07.043307.
Wong SC, Ooi MH, Abdullah AR, Wong SY, Krishnan S, Tio PH, et al. A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006. Tropical Med Int Health. 2008;13(1):52–5. https://doi.org/10.1111/j.1365-3156.2007.01967.x.
Oo PM, Hlaing T, Lwin S, Pittyawonganon C. A large outbreak of Japanese encephalitis in Rakhine State, Myanmar: implication for vaccine policy. Osir. 2016;9(2):8–15.
Ram ST, Neuberger A, Thapa LJ, Vir Singh RP, Shofty B, Schwartz E. Japanese encephalitis among patients with acute encephalitic syndrome admitted to a tertiary hospital in Chitwan, Nepal—a prospective observational study. PLoS One. 2014;9(6). https://doi.org/10.1371/journal.pone.0099999.
Pant SD. Epidemiology of Japanese encephalitis in Nepal. J Nepal Paediatr Soc. 2009;29(1):35–7. https://doi.org/10.3126/jnps.v29i1.1600.
Robertson C, Pant DK, Joshi DD, Sharma M, Dahal M, Stephen C. Comparative spatial dynamics of Japanese encephalitis and acute encephalitis syndrome in Nepal. PLoS One. 2013;8(7):e66168. https://doi.org/10.1371/journal.pone.0066168.
Kumar Pant D, Tenzin T, Chand R, Kumar Sharma B, Raj Bist P. Spatio-temporal epidemiology of Japanese encephalitis in Nepal, 2007-2015. PLoS One. 2017;12(7):2007–15. https://doi.org/10.1371/journal.pone.0180591.
Lopez AL, Aldaba JG, Roque VG, Tandoc AO, Sy AK, Espino FE, et al. Epidemiology of Japanese encephalitis in the Philippines: a systematic review. PLoS Negl Trop Dis. 2015;73(March 2014):1–17. https://doi.org/10.1371/journal.pntd.0003630.
Sunwoo J, Jung K, Lee S, Lee SK, Chu K. Reemergence of Japanese encephalitis in South Korea, 2010-2015. 2016;22(10):1841–3. https://doi.org/10.3201/eid2210.160288.
Choe YJ, Taurel AF, Nealon J, Seo HS, Kim HS. Systematic review of seroepidemiological studies on Japanese encephalitis in the Republic of Korea. Int J Infect Dis. 2018;67:14–9. https://doi.org/10.1016/j.ijid.2017.11.023.
Chang YK, Chang HL, Wu HS, Chen KT. Epidemiological features of Japanese encephalitis in Taiwan from 2000 to 2014. Am J Trop Med Hyg. 2017;96(2):382–8. https://doi.org/10.4269/ajtmh.16-0330.
Olsen SJ, Supawat K, Campbell AP, Anantapreecha S, Liamsuwan S, Tunlayadechanont S, et al. Japanese encephalitis virus remains an important cause of encephalitis in Thailand. Int J Infect Dis. 2010;14(10):e888–92. https://doi.org/10.1016/j.ijid.2010.03.022.
Hills SL, Griggs AC, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg. 2010;82(5):930–6. https://doi.org/10.4269/ajtmh.2010.09-0676.
Yen NT, Duffy MR, Hong NM, Hien NT, Fischer M, Hills SL. Surveillance for Japanese Encephalitis in Vietnam, 1998–2007. 2010;83(4):816–819. doi:https://doi.org/10.4269/ajtmh.2010.10-0262.
SAGE Working Group on Japanese encephalitis vaccines (World Health Organization). Background paper on Japanese encephalitis vaccines. 2016;(March):1–74.
Grossman RA, Edelman R, Willhight M, Pantuwatana S, Udomsakdp S. Study of japanese encephalitis virus in Chiang Mai Valley, Thailand. Am J Epidemiol. 1973;98(2):133–49.
Xufang Y, Huanyu W, Shihong F, Xiaoyan G, Shuye Z, Chunting L, et al. Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou Province, China, in 2006. J Clin Microbiol. 2010;48(4):1343–9. https://doi.org/10.1128/JCM.01009-09.
Feng Y. High incidence of Japanese encephalitis, southern China. Emerg Infect Dis. 2013;19(4):4–5.
Gao X, Li X, Li M, Fu S, Wang H, Lu Z, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in mainland China, 1951–2011. PLoS Negl Trop Dis. 2014;8(8):e3015. https://doi.org/10.1371/journal.pntd.0003015.
Tiwari S, Singh RK, Tiwari R, Dhole TN. Japanese encephalitis: a review of the Indian perspective. Braz J Infect Dis. 2012;16(6):564–73. https://doi.org/10.1016/j.bjid.2012.10.004.
Werlinrud AM, Christiansen CB, Koch A. Japanese encephalitis in a Danish short-term traveler to Cambodia. J Travel Med. 2011;18(6):411–3. https://doi.org/10.1111/j.1708-8305.2011.00565.x.
Chen L et al. Japanese encephalitis in two children—United States, 2010. Morb Mortal Wkly Rep. 2011;60(9).
Tappe D, Nemecek A, Zipp F, Emmerich P, Gabriel M, Günther S, et al. Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. J Clin Virol. 2012;54(3):282–5. https://doi.org/10.1016/j.jcv.2012.03.004.
Langevin S, Libman M, Drebot MA, Laverdière M. A case of Japanese encephalitis virus infection acquired during a trip in Thailand. J Travel Med. 2012;19(2):127–9. https://doi.org/10.1111/j.1708-8305.2011.00582.x.
Hills SL, Stoltey J, Martínez D, Kim PY, Sheriff H, Zangeneh A, et al. A case series of three US adults with Japanese encephalitis, 2010-2012. J Travel Med. 2014;21(5):310–3. https://doi.org/10.1111/jtm.12127.
Lagarde S, Lagier JC, Charrel R, Quérat G, Vanhomwegen J, Desprès P, et al. Japanese encephalitis in a French traveler to Nepal. J Neuro-Oncol. 2014;20(1):99–102. https://doi.org/10.1007/s13365-013-0226-2.
Doti P, Castro P, Martínez MJ, Zboromyrska Y, Aldasoro E, Inciarte A, et al. A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013. Eur Secur. 2013;18(35) https://doi.org/10.2807/1560-7917.ES2013.18.35.20573.
• Huang GKL, Tio SY, Caly L, et al. Prolonged detection of Japanese Encephalitis virus in urine and whole blood in a returned short-term traveler. Open Forum Infect Dis. 2017;ofx203. https://doi.org/10.1093/ofid/ofx203. Report of an Australian man with a fatal case of JE acquired during 8-day travel to Thailand, notable for isolation of JEV RNA from whole blood and culture of JEV from urine sample, findings which previously had not been reported.
Yun S-I, Lee Y-M. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother. 2014;10(2):263–79. https://doi.org/10.4161/hv.26902.
Practices AC on I. Morbidity and mortality weekly report Japanese encephalitis vaccines recommendations of the Advisory Committee on Immunization Practices. Vol 59. 2010.
Firbas C, Jilma B. Product review on the JE vaccine IXIARO. Hum Vaccines Immunother. 2015;11(2):411–20. https://doi.org/10.4161/21645515.2014.983412.
• Saito Y, Moi ML, Takeshita N, Lim CK, Shiba H, Hosono K, et al. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis. 2016;16(1):578. https://doi.org/10.1186/s12879-016-1873-8. Following a single dose of inactivated Vero cell-derived JE vaccine, Japanese adults demonstrated sub-neutralizing levels of cross-reactivity against dengue, implying a risk of more severe infection in the event of dengue infection following JE vaccination
Kumar R, Tripathi P, Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med. 2009;360(14):1465–6. https://doi.org/10.1056/NEJMc0808664.
Public Health Agency of Canada. An Advisory Committee Statement (ACS-4): statement on protection against Japanese Encephalitis. Vol 34; 2008.
European Centre for Disease Control andPrevention. Facts about Japanese encephalitis. https://ecdc.europa.eu/en/japanese-encephalitis/facts. Published 2017. Accessed 23 July 2017.
•• WHO. Japanese encephalitis vaccines: WHO position paper—February 2015. WHO Wkly Epidemiol Rec Relev épidémiologique Hebd. 2015;21(90):69–88. https://doi.org/10.1186/1750-9378-2-15.Voir. Provides most recent data on laboratory detection of JE and vaccine safety and immunogenecity; recommends vaccination in travelers to endemic areas during transmission season who have "extensive outdoor exposure"
National Health Service GB. Japanese encephalitis—prevention. NHS Choices. http://www.nhs.uk/Conditions/Japanese-encephalitis/Pages/Whileyoureaway.aspx. 2016. Accessed 20 July 2017.
Australian Government Department of Health. Japanese encephalitis. The Australian Immunisation Handbook, 10th ed. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part4~handbook10-4-8#4-8-7. 2017. Accessed 23 July 2017.
Himani D, Kumar HBC, Bhilegaonkar KN, Kumar A. Japanese encephalitis: a veterinary perspective. J Foodborne Zoonotic Dis. 2014;2(4):59–67.
Nah J-J, Yang D-K, Kim H-H, Song J-Y. The present and future of veterinary vaccines for Japanese encephalitis in Korea. Clin Exp Vaccine Res. 2015;4:130–6. https://doi.org/10.7774/cevr.2015.4.2.130.
Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009;15(1):1–7. https://doi.org/10.3201/eid1501.080311.
Kim H, Cha GW, Jeong YE, Lee WG, Chang KS, Roh JY, et al. Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS One. 2015;10(2):1–13. https://doi.org/10.1371/journal.pone.0116547.
Dubischar KL, Kadlecek V, Sablan B, et al. Safety of the inactivated Japanese encephalitis virus vaccine IXIARO® in children—an open-label, randomized, active-controlled, phase 3 study. 2017. https://doi.org/10.1097/INF.0000000000001623.
Rossi IA, Genton B. The reliability of pre-travel history to decide on appropriate counseling and vaccinations: a prospective study. J Travel Med. 2012;19(5):284–8. https://doi.org/10.1111/j.1708-8305.2012.00618.x.
Integrated Disease Surveillance Program. National Centre for Disease Control, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. http://idsp.nic.in. 2017.